Stocks/NERV

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

NERV

↓ PDF (Pro)
Minerva Neurosciences Inc Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$6.15
-1.60%today
MKT CAP
$270M
+7.3% · 1Y
Earnings History
+52.2%
-
-481.8%
-30.8%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$6.15
Low
$7.00
Analyst Mean
$9.50
High
$14.00
3 analystsNone
Full Financials
Trailing P/E-
Forward P/E-12.8x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership3.5%
Institutional Ownership84.4%
Short % of Float2.77%
Days to Cover2.9d
1 Week-2.4%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
HolderType% HeldValueΔ SharesAs of
Federated Hermes, Inc.institution12.25%$0.03B+297.53%2025-12-31
Vivo Capital, LLCinstitution9.86%$0.03B+100.00%2025-12-31
Logos Global Management LPinstitution7.55%$0.02B+100.00%2025-12-31
Federated Hermes Equity Funds-Federated Hermes Kaufmann Fundfund7.38%$0.02B+256.47%2026-01-31
Adage Capital Partners GP L.L.C.institution6.47%$0.02B+100.00%2025-12-31
Farallon Capital Management LLCinstitution5.39%$0.01B+100.00%2025-12-31
Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fundfund5.13%$0.01B+193.00%2026-01-31
Spruce Street Capital LPinstitution3.78%$0.01B+100.00%2025-12-31
Ally Bridge Group (NY) LLCinstitution3.78%$0.01B+100.00%2025-12-31
Acuta Capital Partners LLCinstitution1.62%$0.00B+100.00%2025-12-31
Vanguard Group Incinstitution0.57%$0.00B+0.00%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund0.39%$0.00B+0.00%2025-12-31
Renaissance Technologies, LLCinstitution0.34%$0.00B+28.07%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.12%$0.00B+0.00%2025-12-31
Federated Hermes Insurance Series-Federated Hermes Kaufmann Fund IIfund0.06%$0.00B+0.00%2025-12-31
Fidelity Concord Street Trust-Fidelity Total Market Index Fundfund0.05%$0.00B+0.00%2026-02-28
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.04%$0.00B-39.93%2026-02-28
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fundfund0.02%$0.00B+74.48%2026-02-28
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fundfund0.02%$0.00B+0.00%2026-02-28
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for NERV.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.